Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for Hemodialysis
Trial details
- Registry ID
- NCT02644941
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as (regulated as a biological product)
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Comparison of the Human Acellular Vessel (HAV) With ePTFE Grafts as Conduits for HemodialysisNCT02644941 | HUMA | Phase 3 | Completed | 2019-05Actual |
| Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for HemodialysisNCT03183245 | HUMA | Phase 3 | Completed | 2024-04-22Actual |
| Humacyte's HAV for Femoro-Popliteal Bypass in Patients With PADNCT02887859 | HUMA | Phase 2 | Completed | 2020-12Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |